GDEV Inc. Ordinary Shares
GDEVGDEV Inc. Ordinary Shares (GDEV) is a biotechnology company that focuses on developing and commercializing innovative, gene-based therapies for various medical conditions. The company is involved in research and development efforts aimed at advancing treatments in the fields of genetics and regenerative medicine.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| March 11, 2025 | $3.31 | 2025-03-12 | 2025-03-03 |
Dividends Summary
- Consistent Payer: GDEV Inc. Ordinary Shares has rewarded shareholders with 1 dividend payments over the past 0 years.
- Total Returned Value: Investors who held GDEV shares during this period received a total of $3.31 per share in dividend income.
- Latest Payout: The most recent dividend of $3.31/share was paid 318 days ago, on March 11, 2025.
Company News
The gaming industry is benefiting from macroeconomic tailwinds, including interest rate cuts and strong demand for sports betting. Stocks like Flutter Entertainment, DoubleDown Interactive, and GDEV Inc. are expected to gain traction from this upbeat demand.
GDEV Inc. has entered into a Sales Agreement with Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc. to offer and sell up to 1,757,026 ordinary shares held in treasury through an at-the-market offering. The company intends to use the net proceeds for general corporate purposes.
GDEV announces preliminary unaudited results for the first quarter 2024
GDEV announces preliminary unaudited results for the fourth quarter and full year 2023
GDEV announces final results of previously announced self tender offer
